MedPath

To measure the levels of 2 biomarkers in early pregnancy and its association with adverse pregnancy outcomes

Not Applicable
Completed
Conditions
Health Condition 1: O281- Abnormal biochemical finding on antenatal screening of mother
Registration Number
CTRI/2017/02/007821
Lead Sponsor
Dr Belide Shruthi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
282
Inclusion Criteria

1)singleton pregnancy

2)gestational age less than or equal to 18weeks

3)willing to deliver at teaching hospital attached to KLE Universitys J N Medical college,Belagavi.

Exclusion Criteria

1)known case of hypertension

2)known case of overt diabetes mellitus

3)known case of renal/liver disorders

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to measure the levels of homocysteine and asymmetric dimethyl arginine in early pregnancy in this region.Timepoint: early pregnancy(less than or equal to 18 weeks gestation)
Secondary Outcome Measures
NameTimeMethod
any adverse pregnancy outcomes like gestational hypertension, pre-eclampsia, eclampsia, preterm birth, fetal growth restriction, stillbirth, miscarriage, abruptio placenta.Timepoint: at the time of termination of pregnancy.
© Copyright 2025. All Rights Reserved by MedPath